Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 14,160 m |
| EPS, EUR | 12.43 |
| P/B ratio | 3.4 |
| P/E ratio | 17.6 |
| Dividend yield | 0.00% |
| Revenue, EUR | 3,783 m |
| Net income, EUR | -316 m |
| Profit margin | -8.35% |
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 1.14% | Equity United States Health Care Biotech | 69 |
| Vanguard Russell 1000 U.S. Value UCITS ETF USD Dist | 0.04% | Equity United States Value | 2 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.02% | Equity World Social/Environmental | 553 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.02% | Equity North America Social/Environmental | 28 |
| Vanguard Russell U.S. Mid-Cap UCITS ETF USD Dist | 0.11% | Equity United States Mid Cap | 3 |
| JPMorgan Global Equity Active UCITS ETF USD (dist) | 0.52% | Equity World Social/Environmental | 1 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.22% | Equity United States Small Cap | 226 |
| Vanguard FTSE Global All-Cap UCITS ETF USD Dist | 0.01% | Equity World | 9 |
| Année en cours | +46,87% |
| 1 mois | -1,30% |
| 3 mois | +3,92% |
| 6 mois | +32,37% |
| 1 an | +93,74% |
| 3 ans | +65,73% |
| 5 ans | +86,25% |
| Depuis le lancement (MAX) | +116,38% |
| 2025 | +23,85% |
| 2024 | +4,51% |
| 2023 | -24,44% |
| 2022 | +27,06% |
| Volatilité 1 an | 36,27% |
| Volatilité 3 ans | 33,69% |
| Volatilité 5 ans | 31,14% |
| Ratio rendement/risque sur 1 an | 2,58 |
| Ratio rendement/risque sur 3 ans | 0,54 |
| Ratio rendement/risque sur 5 ans | 0,43 |
| Perte maximale sur 1 an | -12,73% |
| Perte maximale sur 3 ans | -37,14% |
| Perte maximale sur 5 ans | -46,60% |
| Perte maximale depuis le lancement | -46,60% |